Is PUMBA (biotech) good enough in terms of placements?

Yes, biotech in PUMBA is definitely a good choice for students, considering the placement statistics in recent years. The course was renamed as MBA in Pharma Biotechnology a few years back. The points below provide a brief overview of the course and its outcomes.

• Every student in the course of Pharma Biotechnology is provided with Marketing as the major specialization.
• The placement scenario of the stream is quite good, with companies from various sectors visiting the campus for placement. Some of the major sectors include Pharmaceuticals, Market Research, Management Consultancy, Bio suppliers, Medical Devices Industry, etc.
• Considering the placement statistics of the 2017 batch, it had an average package of 5.7 LPA till October and has increased by some amount till the end of the session. Within October, 50% of the batch was placed.
• Considering the fee structure and placement packages offers in PUMBA, the institute offers a great return-on-investment
• Some of the companies recruiting students from MBA Pharma Biotechnology are Novartis, Alkem, Watson Pharmaceuticals (Teva Pharmaceuticals’ subsidiary), Sun Pharmaceuticals, Infinity Research, IQVIA, Indegene, Thermofisher, etc.
• The placement statistics in MBA Pharma Biotechnology are highly dependent on the Macroeconomic conditions of the type of industries candidates are interested in. So, students need to keep themselves updated and corporate ready.

Therefore, MBA Pharma Biotechnology is definitely a good choice for students who are interested in this stream of management, providing decent placement opportunities in-campus.